Pharmafile Logo

Lonza

Lonza Launches Media Development Lab in Singapore for Cell Culture Media Optimisation

New media development services designed to optimize cell culture media development and identify robust, scalable media formulations driving cell culture performance and reliability The offering is designed to improve performance, reduce risk, and help ensure smooth scale-up into manufacturing The service has been offered at Lonza’s Singapore (SG) site since March. 26 March 2026 --...

Lonza‪s API Mid-Scale Manufacturing Facility Expansion in Nansha Enters Commercial Operation

Expanded capacity in Nansha, China, will support mid-scale manufacturing to ensure a smooth transition between early-phase and large-scale commercial production. Capabilities add to Lonzaís integrated global manufacturing network, which maintains rigorous quality and regulatory standards around the world

“Genome Editing of Immune Cells” – New Lonza Virtual Event

Basel, Switzerland, 06 September 2022 - On September 20, 2022, Lonza will host a free virtual workshop on using genome editing technologies for cell and gene therapies and drug discovery. The 3-hour workshop brings together renowned genome editing experts from across industry and academia and comprises four interactive speaker sessions and a concluding panel discussion....
https://www.lonza.com/
Muenchensteinerstrasse 38 Basel, 4002